Diabetes drug showdown: which Add-On works better?
Disease control
Completed
This study compared two different add-on medications for people with type 2 diabetes whose blood sugar wasn't well controlled on their current two-drug therapy. About 133 participants in South Korea were randomly assigned to add either pioglitazone or dapagliflozin to their exist…
Phase: PHASE4 • Sponsor: Celltrion Pharm, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC